Literature DB >> 10216523

Risk of iodine-induced thyrotoxicosis after coronary angiography: an investigation in 788 unselected subjects.

G Hintze1, O Blombach, H Fink, U Burkhardt, J Köbberling.   

Abstract

In this study, the risk of iodine-induced thyrotoxicosis in unselected patients from an iodine-deficient area was investigated. The patients were consecutively enrolled. Thyroid hormone values and urinary iodine excretion were determined before, as well as 1, 4 and 12 weeks after iodine contamination by coronary angiography. Two of 788 unselected patients developed hyperthyroidism within 12 weeks. The two patients did not belong to a risk group for iodine-induced thyrotoxicosis (i.e. old people, patients with goiter or possible thyroid autonomy, low TSH). Both patients had normal TSH levels at baseline and ultrasound of the thyroid was without evidence of nodules. The study shows that in euthyroid unselected patients from an iodine-deficient area short-term iodine contamination by contrast media rarely leads to hyperthyroidism. On account of these facts, prophylactic therapy, e.g. by perchlorate or thiamazole, is not generally recommended, because the risk of side-effects is perhaps even greater than the risk of iodine-induced thyrotoxicosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10216523     DOI: 10.1530/eje.0.1400264

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  14 in total

1.  Coronary physiology and percutaneous intervention managed with gadolinium road mapping and intravascular ultrasound in hyperthyroidism.

Authors:  Peter Tajti; Mohamed Ayoub; Thomas Nuehrenberg; Kambis Mashayekhi
Journal:  Cardiol J       Date:  2021-03-01       Impact factor: 2.737

2.  [Drug therapy in interventional radiology].

Authors:  M Sumkauskaite; M Bryant; N Kortes; U Stampfl; B Radeleff
Journal:  Radiologe       Date:  2015-06       Impact factor: 0.635

3.  Iodinated contrast-induced thyrotoxicosis.

Authors:  Paul Dunne; Nisha Kaimal; John MacDonald; Akheel A Syed
Journal:  CMAJ       Date:  2012-11-12       Impact factor: 8.262

4.  N-acetylcysteine administration prevents nonthyroidal illness syndrome in patients with acute myocardial infarction: a randomized clinical trial.

Authors:  Josi Vidart; Simone Magagnin Wajner; Rogério Sarmento Leite; André Manica; Beatriz D Schaan; P Reed Larsen; Ana Luiza Maia
Journal:  J Clin Endocrinol Metab       Date:  2014-12       Impact factor: 5.958

5.  The dangers of iodine-based contrasts in an elderly patient with thyroid disease.

Authors:  David Ledingham; Peter Carey; Shahid Junejo
Journal:  BMJ Case Rep       Date:  2015-03-24

Review 6.  [Therapy and prevention of hyperthyroidism].

Authors:  U Woenckhaus; C Girlich
Journal:  Internist (Berl)       Date:  2005-12       Impact factor: 0.743

7.  2021 European Thyroid Association Guidelines for the Management of Iodine-Based Contrast Media-Induced Thyroid Dysfunction.

Authors:  Tomasz Bednarczuk; Thomas H Brix; Wolfgang Schima; Georg Zettinig; George J Kahaly
Journal:  Eur Thyroid J       Date:  2021-06-16

8.  Prevention of Iodinated Contrast Media-Induced Hyperthyroidism in Patients with Euthyroid Goiter.

Authors:  Katarzyna Pelewicz; Rafał Wolny; Tomasz Bednarczuk; Piotr Miśkiewicz
Journal:  Eur Thyroid J       Date:  2021-04-13

9.  Effect of iodinated contrast media on thyroid function in adults.

Authors:  Aart J van der Molen; Henrik S Thomsen; Sameh K Morcos
Journal:  Eur Radiol       Date:  2004-02-28       Impact factor: 5.315

Review 10.  [Prevention and multimodal therapy of hyperthyroidism].

Authors:  K-D Palitzsch
Journal:  Internist (Berl)       Date:  2008-12       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.